Perventricular Closure of Atrial Septal Defect and Ventricular Septal Defect Through a Single Port: The Initial Experience_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

梅富杨 , Hareeswara SAdugula , 凌云飞 ,  安琪

四川大学华西医院心脏大血管外科(成都 610041);

Corresponding author：

安琪, Email: anqi126@126.com

Keywords：

经胸微创封堵术; 房间隔缺损; 室间隔缺损; 封堵

DOI：

10.7507/1007-4848.20160149

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的评价单穿刺点经胸微创封堵治疗房间隔缺损（ASD）合并室间隔缺损（VSD）的安全性及有效性。方法纳入2014年6月至2015年8月于我院成功完成单穿刺点经胸微创封堵术治疗ASD合并VSD的8例患儿，分析患儿在术后第l个月、3个月、6个月的门诊随访资料。观察围术期及随访期间患者残余分流、瓣膜反流、心律失常等并发症发生情况。结果 8例患儿中，术后早期均无残余分流、心律失常，微量三尖瓣反流（TR）患者1例（12.5%）。平均随访时间5～9（6±2）个月，各瓣膜均未发现中度及以上反流，未发现存在血栓、严重心律失常、死亡的患者。结论单穿刺点经胸微创封堵治疗ASD合并VSD安全、有效，且更为微创。

Citation： 梅富杨, Hareeswara SAdugula, 凌云飞, 安琪. Perventricular Closure of Atrial Septal Defect and Ventricular Septal Defect Through a Single Port: The Initial Experience. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2016, 23(6): 627-630. doi: 10.7507/1007-4848.20160149 Copy

1.	Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Circulation, 1971, 43:323-332.
2.	Limperopoulos C, Majnemer A, Shevell MI, et al. Predictors of developmental disabilities after open-heart surgery in young children with congenital heart defects. Pediatr, 2002, 141:51-58.
3.	Stephens RS, Shah AS, Whitman GJ. Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg, 2013, 95(3):1122-1129.
4.	McGregor L, Martin J, McGregor JL. Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Bioscic, 2006, 11:830-837.
5.	Bellinger DC, Wypij D, duPlessis AJ, et al. Neurodevelopmental status at eight years in children with dextrotransposition of the great arteries:the Boston Circulatory Arrest Trial. Thorac Cardiovasc Surg, 2003, 126(5):1385-1396.
6.	Noris M, Remuzzi G. New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. Am J Kidney Dis, 1995, 26(3):541-548.
7.	Amin Z, Berry JM, Foker JE, et al. Intraoperative closure of muscular ventricular septal defect in a canine model and application of the technique in a baby. Thorac Cardiovasc Surg, 1998, 115(6):1374-1376.
8.	Gan C, An Q, Lin K, et al. Perventricular device closure of ventricular septal defects:six months results in 30 young children. Ann Thorac Surg, 2008, 86(1):142-146.
9.	Thanopoulos BD, Tsaousis GS, Karanasios E, et al. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder:preliminary experience in children. Heart, 2003, 89(8):918-922.
10.	Amin Z, Danford DA, Lof J, et al. Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass:prelimnary results with the perventricular technique. Thorac Cardiovasc Surg, 2004, 127:234-241.
11.	Szkutnik M, Qureshi SA, Kusa J, et al. Use of the amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart, 2007, 93(3):355-358.
12.	Tao K, Lin K, Shi YK, et al. Perventricular device closure of perimembranous ventricular septa defects in 61 young children:Early and midterm follow-up results. Thorac Cardiovasc Surg, 2010, 140(4):864-870.
13.	Tucker EM, Pyles LA, Bass JL, et al. Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect. Am Coll Cardiol, 2007, 50(12):1196-1200.
14.	Bass JL, Kalra GS, Arora R, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv, 2003, 58(2):238-245.
15.	Masura J, Gao W, Gavora P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device:multicenter follow-up study. Pediatr Cardiol, 2005, 26(3):216-219.
16.	Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder:immediate and midterm results of an international registry. Catheter Cardiovasc Interv, 2006, 68(4):620-628.
17.	Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol, 2005, 96(12A):52L-58L.
18.	Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. Cardiol Young, 2007, 17:243-253.
19.	Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects:early and long-term results. Am Coll Cardiol, 2007, 50(12):1189-1195.
20.	Butera G, Carminati M, Chessa M, et al. Percutaneous closure of ventricular septal defects in children aged < 12:early and mid-term results. Eur Heart J, 2006, 27(23):2889-2895.

1. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Circulation, 1971, 43:323-332.
2. Limperopoulos C, Majnemer A, Shevell MI, et al. Predictors of developmental disabilities after open-heart surgery in young children with congenital heart defects. Pediatr, 2002, 141:51-58.
3. Stephens RS, Shah AS, Whitman GJ. Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg, 2013, 95(3):1122-1129.
4. McGregor L, Martin J, McGregor JL. Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Bioscic, 2006, 11:830-837.
5. Bellinger DC, Wypij D, duPlessis AJ, et al. Neurodevelopmental status at eight years in children with dextrotransposition of the great arteries:the Boston Circulatory Arrest Trial. Thorac Cardiovasc Surg, 2003, 126(5):1385-1396.
6. Noris M, Remuzzi G. New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. Am J Kidney Dis, 1995, 26(3):541-548.
7. Amin Z, Berry JM, Foker JE, et al. Intraoperative closure of muscular ventricular septal defect in a canine model and application of the technique in a baby. Thorac Cardiovasc Surg, 1998, 115(6):1374-1376.
8. Gan C, An Q, Lin K, et al. Perventricular device closure of ventricular septal defects:six months results in 30 young children. Ann Thorac Surg, 2008, 86(1):142-146.
9. Thanopoulos BD, Tsaousis GS, Karanasios E, et al. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder:preliminary experience in children. Heart, 2003, 89(8):918-922.
10. Amin Z, Danford DA, Lof J, et al. Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass:prelimnary results with the perventricular technique. Thorac Cardiovasc Surg, 2004, 127:234-241.
11. Szkutnik M, Qureshi SA, Kusa J, et al. Use of the amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart, 2007, 93(3):355-358.
12. Tao K, Lin K, Shi YK, et al. Perventricular device closure of perimembranous ventricular septa defects in 61 young children:Early and midterm follow-up results. Thorac Cardiovasc Surg, 2010, 140(4):864-870.
13. Tucker EM, Pyles LA, Bass JL, et al. Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect. Am Coll Cardiol, 2007, 50(12):1196-1200.
14. Bass JL, Kalra GS, Arora R, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv, 2003, 58(2):238-245.
15. Masura J, Gao W, Gavora P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device:multicenter follow-up study. Pediatr Cardiol, 2005, 26(3):216-219.
16. Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder:immediate and midterm results of an international registry. Catheter Cardiovasc Interv, 2006, 68(4):620-628.
17. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol, 2005, 96(12A):52L-58L.
18. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. Cardiol Young, 2007, 17:243-253.
19. Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects:early and long-term results. Am Coll Cardiol, 2007, 50(12):1189-1195.
20. Butera G, Carminati M, Chessa M, et al. Percutaneous closure of ventricular septal defects in children aged < 12:early and mid-term results. Eur Heart J, 2006, 27(23):2889-2895.

Previous Article
晚期肺癌肋骨骨转移患者行减症手术治疗六例
Next Article
Clinical Analysis of 21 Patients with Cardiac Surgery by Cardiopulmonary Bypass during Pregnancy

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Perventricular Closure of Atrial Septal Defect and Ventricular Septal Defect Through a Single Port: The Initial Experience

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content